Ona Therapeutics's $86.6M Series B: Barcelona's ADC Cancer Bet
Barcelona biopharma Ona Therapeutics closed an oversubscribed $86.6M Series B in June 2026 to advance first-in-class antibody-drug conjugates for resistant cancers.
healthtech - VC Tracker Resources
Discover comprehensive resources and guides related to healthtech. Our comprehensive guides cover VC analysis preparation, investment resources, and practical advice for investors and analysts.
Whether you're an investor preparing for market analysis, a portfolio manager helping with investment tracking, or an analyst looking for resources, you'll find valuable insights in the articles below.
Related Articles (18 articles)
Semble's £30M Series C: Modern Software for Healthcare Providers
UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.
Garner Health's $100M Series E at $2.74B: Data-Driven Provider Selection
Garner Health raised $100M Series E led by Index Ventures in May 2026 at a $2.74B valuation, scaling its data platform for finding high-quality healthcare providers.
MiRus's $1.5B: A Medtech Megaround in an AI-Dominated Market
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Nourish's $100M Series C: Dietitian-Led Metabolic Health Hits $215M Total Funding
Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.
Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters
Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.